Short description
Elex biotech develops drugs for the treatment of cardiovascular diseases.
Description
ELEX Biotech develops small-molecule pharmaceutical drugs for the management and cure of cardiovascular diseases such as heart failure and arrhythmias, enabling physicians to offer effective treatments for heart-related diseases. These compounds modulate the function of calcium channels that control the contraction of cardiac muscle.
Total funding
$$43214321
Sign in for full access
Location
Portland, Oregon, United States, North America
Founded on
January 1, 2009
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Noaccess
Sign in for full access
Founders
Doug Kawahara, Guy Salama, Jonathan Abramson, Sandra Shotwell, Xander Wehrens